A's re-sign Tomko, add Jennings to pitching staff

0 Comments

The A’s added two veteran right-handers on Sunday, re-signing the rehabbing Brett Tomko and picking up Jason Jennings on a minor league contract.
Tomko, who went 4-1 with a 2.95 ERA in six starts for the A’s down the stretch last year, is still working his way back from an arm injury and isn’t expected to be an option for Oakland until May at the earliest.
Jennings was shifted to the bullpen by the Rangers last year and had a 4.13 ERA in 61 innings before losing his spot. He started off with a 3.26 ERA in 47 innings before the break, but he gave up 11 earned runs in 14 innings afterwards and was released.
The A’s said they planned to stretch Jennings back out and allow him to compete for a rotation spot. He’d be a long shot to make the team either way, but he probably will have a better shot of beating out Trevor Cahill and Gio Gonzalez for a rotation spot than he would overtaking any of the power bullpen arms.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.